Experience
Capsugel Belgium NV
Innercap Technologies
Finnegan successfully represented Capsugel Belgium in one of the first completed inter partes review (IPR) proceedings at the U.S. Patent and Trademark Office (USPTO). Capsugel challenged all 26 issued claims of a patent owned by Innercap Technologies, and an adverse judgment was entered by the Patent Trial and Appeal Board (PTAB) cancelling all of the claims instituted as part of the post-grant challenge. The patent was directed to a pharmaceutical capsule.
Capsugel Belgium NV v. Innercap Technologies, IPR2013-00331, PTAB, Judges Crumbley, Elluru, Green
SAP prevails in first PTAB post-grant review decision
SAP America Inc.
Toyota Motor Corp.
Finnegan client BTG prevails in EPO opposition proceedings in the field of vein sclerotherapy
BTG International, Ltd.
Unified Patents prevails in Federal Circuit appeal challenging PTAB final written decision
Unified Patents, Inc.
William Hill U.S. Holdco, Inc. v. CG Technology Development, LLC
CG Technology Development, LLC
USPTO cancels all claims for Finnegan client CRS in second CBM proceeding (in favor of)
CRS Advanced Technologies
Finnegan client successfully uses CBM to invalidate a competitor’s patents
Fidelity National Information Services, Inc.; Metavante Corporation
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.